| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cortexyme Inc (NASDAQ: CRTX)
CRTX Technical Analysis
5
| As on 30th Sep 2022 CRTX SHARE Price closed @ 1.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 41.73 & Strong Sell for SHORT-TERM with Stoploss of 43.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRTXSHARE Price
| Open | 1.29 | Change | Price | % |
| High | 1.46 | 1 Day | -0.07 | -5.00 |
| Low | 1.29 | 1 Week | -0.12 | -8.28 |
| Close | 1.33 | 1 Month | -0.72 | -35.12 |
| Volume | 131986 | 1 Year | -37.37 | -96.56 |
| 52 Week High 120.21 | 52 Week Low 1.26 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRTX Daily Charts |
CRTX Intraday Charts |
Whats New @ Bazaartrend |
CRTX Free Analysis |
|
|
CRTX Important Levels Intraday
| RESISTANCE | 1.66 |
| RESISTANCE | 1.55 |
| RESISTANCE | 1.49 |
| RESISTANCE | 1.42 |
| SUPPORT | 1.24 |
| SUPPORT | 1.17 |
| SUPPORT | 1.11 |
| SUPPORT | 1.00 |
CRTX Forecast April 2024
| 4th UP Forecast | 36.67 |
| 3rd UP Forecast | 25.34 |
| 2nd UP Forecast | 18.33 |
| 1st UP Forecast | 11.33 |
| 1st DOWN Forecast | -8.67 |
| 2nd DOWN Forecast | -15.67 |
| 3rd DOWN Forecast | -22.68 |
| 4th DOWN Forecast | -34.01 |
CRTX Weekly Forecast
| 4th UP Forecast | 10.60 |
| 3rd UP Forecast | 7.63 |
| 2nd UP Forecast | 5.79 |
| 1st UP Forecast | 3.95 |
| 1st DOWN Forecast | -1.29 |
| 2nd DOWN Forecast | -3.13 |
| 3rd DOWN Forecast | -4.97 |
| 4th DOWN Forecast | -7.94 |
CRTX Forecast2024
| 4th UP Forecast | 234.07 |
| 3rd UP Forecast | 159.43 |
| 2nd UP Forecast | 113.29 |
| 1st UP Forecast | 67.16 |
| 1st DOWN Forecast | -64.5 |
| 2nd DOWN Forecast | -110.63 |
| 3rd DOWN Forecast | -156.77 |
| 4th DOWN Forecast | -231.41 |
Cortexyme Inc ( NASDAQ USA Symbol : CRTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRTX Business Profile
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Address: 269 East Grand Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service